Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01943162
Other study ID # W81XWH-11-1-0641
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date August 2012
Est. completion date September 2017

Study information

Verified date May 2018
Source San Diego Veterans Healthcare System
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study will test a modification of Cognitive Processing Therapy (CPT) for Post-Traumatic Stress Disorder, (PTSD) in which CPT is augmented with compensatory cognitive rehabilitation principles from the Cognitive Symptom Management and Rehabilitation Therapy (CogSMART) intervention to create a hybrid treatment, SMART-CPT. This study investigates the efficacy of SMART-CPT in improving PTSD and post-concussive symptoms, cognition, quality of life, and treatment compliance in those with a history of mild to moderate TBI and persistent cognitive complaints.


Recruitment information / eligibility

Status Completed
Enrollment 108
Est. completion date September 2017
Est. primary completion date September 2017
Accepts healthy volunteers No
Gender All
Age group 18 Years to 60 Years
Eligibility Inclusion Criteria:

1) OEF/OIF veteran; 2) Current diagnosis of PTSD; 3) History of mild-to-moderate TBI; 4) Subjective cognitive complaints; 5) No anticipated/pending medication changes; 6) Written informed consent to participate in the study. -

Exclusion Criteria:1) Active substance dependence, 2) Suicidal intent or attempt within the previous month; 3) Current psychotic disorder; 4) Dementia; 5) Non-English speaking; 6) Participation in other intervention studies.

Study Design


Related Conditions & MeSH terms

  • PTSD With a History of Mild to Moderate TBI

Intervention

Behavioral:
CPT


Locations

Country Name City State
United States VA San Diego Healthcare System San Diego California

Sponsors (2)

Lead Sponsor Collaborator
San Diego Veterans Healthcare System Congressionally Directed Medical Research Programs

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary PTSD Checklist change from baseline PTSD Checklist at 12 weeks (post-treatment)